Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Clearside Biomedical Inc (CLSD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Clearside Biomedical's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.310 -0.010    -0.76%
05:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
1.350
+0.040
+3.046%
6:41:57 - Real-time Data
  • Volume: 98,434
  • Bid/Ask: 1.270 / 1.350
  • Day's Range: 1.290 - 1.350
Type:  Equity
Market:  United States
Clearside Biomedical 1.310 -0.010 -0.76%

Clearside Biomedical Inc Company Profile

 
Get an in-depth profile of Clearside Biomedical Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

30

Equity Type

ORD

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Contact Information

Address 900 North Point Parkway Suite 200
Alpharetta, 30005
United States
Phone 678 270 3631
Fax 678 270 4033

Top Executives

Name Age Since Title
George M. Lasezkay 71 2017 President, CEO & Director
Christy L. Shaffer 65 2012 Independent Director
William D. Humphries 57 2012 Independent Director
Richard J. Croarkin 69 2016 Independent Director
Benjamin R. Yerxa 57 2022 Independent Director
Jeffrey L. Edwards 62 2018 Independent Director
Clay Bernardin Thorp 55 2012 Independent Chair of the Board
Carl D. Regillo - 2020 Member of Scientific Advisory Board
Nancy June Hutson 74 2020 Independent Director
David M. Brown - 2020 Member of Scientific Advisory Board
David S. Boyer - 2020 Member of Scientific Advisory Board
Arshad M. Khanani - 2023 Member of Scientific Advisory Board
Lejla Vajzovic - 2023 Member of Scientific Advisory Board
Thomas A. Ciulla 59 2018 Chairman of Scientific Advisory Board
Anthony S. Gibney 53 2024 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CLSD Comments

Write your thoughts about Clearside Biomedical Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email